$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 06 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 74.11 | 47,376 | 3,511,244 | 3,020,386 | 3.1 M to 3 M (-1.54 %) |
| Sep 06 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Aug 14 2018 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Option Exercise | M | 0.00 | 1,070 | 0 | 1,070 | |
| Aug 14 2018 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Payment of Exercise | F | 76.73 | 489 | 37,521 | 20,612 | 21.1 K to 20.6 K (-2.32 %) |
| Aug 14 2018 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Buy | M | 0.00 | 1,070 | 0 | 21,101 | 20 K to 21.1 K (+5.34 %) |
| Aug 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 200,000 | |
| Aug 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 77.85 | 50,000 | 3,892,650 | 3,017,762 | 3.1 M to 3 M (-1.63 %) |
| Aug 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Aug 02 2018 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Option Exercise | M | 0.00 | 2,000 | 0 | 2,140 | |
| Aug 02 2018 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Payment of Exercise | F | 77.83 | 910 | 70,825 | 20,031 | 20.9 K to 20 K (-4.35 %) |
| Aug 02 2018 | GILD | GILEAD SCIENCES IN ... | Pletcher Brett A | EVP, Gen Counsel & ... | Buy | M | 0.00 | 2,000 | 0 | 20,941 | 18.9 K to 20.9 K (+10.56 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 250,000 | |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 71.36 | 300 | 21,408 | 3,017,762 | 3 M to 3 M (-0.01 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 250,000 | |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 70.80 | 49,700 | 3,518,874 | 3,018,062 | 3.1 M to 3 M (-1.62 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 71.36 | 300 | 21,408 | 3,017,762 | 3 M to 3 M (-0.01 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 70.80 | 49,700 | 3,518,874 | 3,018,062 | 3.1 M to 3 M (-1.62 %) |
| Jul 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Jul 03 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 1,623 | 0 | 23,156 | |
| Jul 02 2018 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 53 | 0 | 6,595 | |
| Jul 02 2018 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 53 | 0 | 6,595 | |
| Jul 02 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 173 | 0 | 21,533 | |
| Jul 02 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 173 | 0 | 21,533 | |
| Jul 02 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 173 | 0 | 21,533 | |
| Jul 02 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 173 | 0 | 21,533 | |
| Jul 02 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 173 | 0 | 21,533 | |
| Jul 02 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 173 | 0 | 21,533 | |
| Jun 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 300,000 | |
| Jun 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 68.13 | 50,000 | 3,406,495 | 3,017,762 | 3.1 M to 3 M (-1.63 %) |
| Jun 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | A | 0.00 | 2,283 | 0 | 2,593 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | A | 65.69 | 9,496 | 623,792 | 9,496 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 2,283 | 0 | 6,311 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 65.69 | 9,496 | 623,792 | 9,496 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 0.00 | 2,283 | 0 | 2,283 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | A | 65.69 | 9,496 | 623,792 | 9,496 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 0.00 | 2,283 | 0 | 2,283 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | A | 65.69 | 9,496 | 623,792 | 9,496 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Option Exercise | A | 0.00 | 2,283 | 0 | 2,283 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | MANWANI HARISH | Director | Option Exercise | A | 65.69 | 9,496 | 623,792 | 9,496 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | Kramer Kelly A. | Director | Option Exercise | A | 0.00 | 2,283 | 0 | 4,524 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | Kramer Kelly A. | Director | Option Exercise | A | 65.69 | 9,496 | 623,792 | 9,496 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 2,283 | 0 | 7,894 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 65.69 | 9,496 | 623,792 | 9,496 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 0.00 | 2,283 | 0 | 2,283 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | A | 65.69 | 9,496 | 623,792 | 9,496 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 0.00 | 2,283 | 0 | 2,763 | |
| May 11 2018 | GILD | GILEAD SCIENCES IN ... | BARTON JACQUELINE K | Director | Option Exercise | A | 65.69 | 9,496 | 623,792 | 9,496 | |
| May 10 2018 | GILD | GILEAD SCIENCES IN ... | McHutchison John G | Chief Scientific Of ... | Option Exercise | A | 65.22 | 79,710 | 5,198,686 | 79,710 | |
| May 10 2018 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Option Exercise | M | 0.00 | 2,241 | 0 | 0 | |
| May 10 2018 | GILD | GILEAD SCIENCES IN ... | WOLD OLSEN PER | Director | Buy | M | 0.00 | 2,241 | 0 | 95,571 | 93.3 K to 95.6 K (+2.40 %) |
| May 10 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 0.00 | 2,241 | 0 | 0 | |
| May 10 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 0.00 | 2,241 | 0 | 54,860 | 52.6 K to 54.9 K (+4.26 %) |
| May 10 2018 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 0.00 | 2,241 | 0 | 0 | |
| May 10 2018 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 0.00 | 2,241 | 0 | 124,499 | 122.3 K to 124.5 K (+1.83 %) |
| May 08 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | M | 27.07 | 80,000 | 2,165,600 | 0 | |
| May 08 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Buy | M | 27.07 | 80,000 | 2,165,600 | 1,294,306 | 1.2 M to 1.3 M (+6.59 %) |
| May 08 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 26.62 | 5,836 | 155,325 | 0 | |
| May 08 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 65.09 | 5,836 | 379,885 | 52,619 | 58.5 K to 52.6 K (-9.98 %) |
| May 08 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 26.62 | 5,836 | 155,325 | 58,455 | 52.6 K to 58.5 K (+11.09 %) |
| May 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 350,000 | |
| May 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 72.19 | 50,000 | 3,609,660 | 3,017,762 | 3.1 M to 3 M (-1.63 %) |
| May 03 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Apr 30 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 26.62 | 5,833 | 155,245 | 5,836 | |
| Apr 30 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 73.91 | 5,833 | 431,117 | 52,619 | 58.5 K to 52.6 K (-9.98 %) |
| Apr 30 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 26.62 | 5,833 | 155,245 | 58,452 | 52.6 K to 58.5 K (+11.09 %) |
| Apr 23 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 26.62 | 5,833 | 155,245 | 11,669 | |
| Apr 23 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 73.77 | 5,333 | 393,435 | 52,619 | 58 K to 52.6 K (-9.20 %) |
| Apr 23 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 73.39 | 500 | 36,696 | 57,952 | 58.5 K to 58 K (-0.86 %) |
| Apr 23 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 26.62 | 5,833 | 155,245 | 58,452 | 52.6 K to 58.5 K (+11.09 %) |
| Apr 16 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 26.62 | 5,833 | 155,245 | 17,502 | |
| Apr 16 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 75.56 | 5,833 | 440,741 | 52,619 | 58.5 K to 52.6 K (-9.98 %) |
| Apr 16 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 26.62 | 5,833 | 155,245 | 58,452 | 52.6 K to 58.5 K (+11.09 %) |
| Apr 09 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 26.62 | 5,833 | 155,245 | 23,335 | |
| Apr 09 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 74.47 | 5,833 | 434,384 | 52,619 | 58.5 K to 52.6 K (-9.98 %) |
| Apr 09 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 26.62 | 5,833 | 155,245 | 58,452 | 52.6 K to 58.5 K (+11.09 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 400,000 | |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 74.98 | 700 | 52,484 | 3,017,762 | 3 M to 3 M (-0.02 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 74.33 | 9,962 | 740,466 | 3,018,462 | 3 M to 3 M (-0.33 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 73.39 | 13,080 | 959,890 | 3,028,424 | 3 M to 3 M (-0.43 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Sell | S | 72.51 | 26,258 | 1,903,965 | 3,041,504 | 3.1 M to 3 M (-0.86 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 26.62 | 5,833 | 155,245 | 29,168 | |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 74.93 | 5,833 | 437,067 | 52,619 | 58.5 K to 52.6 K (-9.98 %) |
| Apr 04 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 26.62 | 5,833 | 155,245 | 58,452 | 52.6 K to 58.5 K (+11.09 %) |
| Apr 02 2018 | GILD | GILEAD SCIENCES IN ... | Lofton Kevin E | Director | Option Exercise | A | 0.00 | 160 | 0 | 21,359 | |
| Apr 02 2018 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | A | 0.00 | 205 | 0 | 27,376 | |
| Apr 02 2018 | GILD | GILEAD SCIENCES IN ... | Whitley Richard James | Director | Option Exercise | A | 0.00 | 49 | 0 | 6,542 | |
| Mar 26 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 26.62 | 5,833 | 155,245 | 35,001 | |
| Mar 26 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 75.02 | 5,833 | 437,588 | 52,619 | 58.5 K to 52.6 K (-9.98 %) |
| Mar 26 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 26.62 | 5,833 | 155,245 | 58,452 | 52.6 K to 58.5 K (+11.09 %) |
| Mar 20 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Option Exercise | M | 26.62 | 5,833 | 155,245 | 40,834 | |
| Mar 20 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Sell | S | 80.09 | 5,833 | 467,138 | 52,619 | 58.5 K to 52.6 K (-9.98 %) |
| Mar 20 2018 | GILD | GILEAD SCIENCES IN ... | Cogan John Francis | Director | Buy | M | 26.62 | 5,833 | 155,245 | 58,452 | 52.6 K to 58.5 K (+11.09 %) |
| Mar 13 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | A | 0.00 | 310 | 0 | 310 | |
| Mar 13 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Director | Option Exercise | A | 80.72 | 1,309 | 105,662 | 1,309 | |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Option Exercise | M | 0.00 | 178 | 0 | 27,170 | |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MOORE NICHOLAS G | Director | Buy | M | 0.00 | 178 | 0 | 12,233 | 12.1 K to 12.2 K (+1.48 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Option Exercise | M | 40.56 | 17,250 | 699,660 | 55,596 | |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Sell | S | 79.41 | 3,099 | 246,097 | 44,426 | 47.5 K to 44.4 K (-6.52 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Sell | S | 78.92 | 16,200 | 1,278,575 | 47,525 | 63.7 K to 47.5 K (-25.42 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Sell | S | 77.64 | 5,701 | 442,643 | 63,725 | 69.4 K to 63.7 K (-8.21 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Buy | M | 40.56 | 17,250 | 699,660 | 69,426 | 52.2 K to 69.4 K (+33.06 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Option Exercise | M | 23.60 | 50,000 | 1,180,000 | 450,000 | |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 79.49 | 6,523 | 518,522 | 3,017,762 | 3 M to 3 M (-0.22 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 78.95 | 26,575 | 2,098,200 | 3,024,285 | 3.1 M to 3 M (-0.87 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Sell | S | 77.84 | 16,902 | 1,315,653 | 3,050,860 | 3.1 M to 3.1 M (-0.55 %) |
| Mar 05 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Buy | M | 23.60 | 50,000 | 1,180,000 | 3,067,762 | 3 M to 3.1 M (+1.66 %) |
| Mar 02 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Sell | S | 80.31 | 5,000 | 401,566 | 105,405 | 110.4 K to 105.4 K (-4.53 %) |
| Mar 02 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 6,588 | 0 | 110,405 | 103.8 K to 110.4 K (+6.35 %) |
| Mar 02 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 6,588 | 0 | 17,161 | 23.7 K to 17.2 K (-27.74 %) |
| Mar 02 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 340 | 0 | 103,817 | 103.5 K to 103.8 K (+0.33 %) |
| Mar 02 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Gift | G | 0.00 | 340 | 0 | 23,749 | 24.1 K to 23.7 K (-1.41 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Payment of Exercise | F | 80.69 | 5,894 | 475,587 | 52,176 | 58.1 K to 52.2 K (-10.15 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Grant | A | 0.00 | 5,672 | 0 | 58,070 | 52.4 K to 58.1 K (+10.82 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Grant | A | 0.00 | 14,320 | 0 | 52,398 | 38.1 K to 52.4 K (+37.61 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Grant | A | 62.35 | 340 | 21,198 | 38,078 | 37.7 K to 38.1 K (+0.90 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Payment of Exercise | F | 80.69 | 5,690 | 459,126 | 24,089 | 29.8 K to 24.1 K (-19.11 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 5,183 | 0 | 29,779 | 24.6 K to 29.8 K (+21.07 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 0.00 | 14,654 | 0 | 24,596 | 9.9 K to 24.6 K (+147.39 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Washington Robin L | EVP, CFO | Grant | A | 62.35 | 340 | 21,198 | 9,942 | 9.6 K to 9.9 K (+3.54 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Payment of Exercise | F | 80.69 | 8,009 | 646,246 | 1,214,306 | 1.2 M to 1.2 M (-0.66 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 0.00 | 7,709 | 0 | 1,222,315 | 1.2 M to 1.2 M (+0.63 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 0.00 | 48,342 | 0 | 1,214,606 | 1.2 M to 1.2 M (+4.15 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Grant | A | 62.35 | 340 | 21,198 | 1,166,264 | 1.2 M to 1.2 M (+0.03 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 9,393 | 0 | 2,317,800 | 2.3 M to 2.3 M (+0.41 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Gift | G | 0.00 | 9,393 | 0 | 19,602 | 29 K to 19.6 K (-32.40 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Payment of Exercise | F | 80.69 | 7,071 | 570,559 | 28,995 | 36.1 K to 29 K (-19.61 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 6,805 | 0 | 36,066 | 29.3 K to 36.1 K (+23.26 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 0.00 | 16,468 | 0 | 29,261 | 12.8 K to 29.3 K (+128.73 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | BISCHOFBERGER NORBERT W | EVP, R&D and CSO | Grant | A | 62.35 | 340 | 21,198 | 12,793 | 12.5 K to 12.8 K (+2.73 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Payment of Exercise | F | 80.69 | 19,354 | 1,561,674 | 3,017,762 | 3 M to 3 M (-0.64 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 0.00 | 18,630 | 0 | 3,037,116 | 3 M to 3 M (+0.62 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 0.00 | 21,380 | 0 | 3,018,486 | 3 M to 3 M (+0.71 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | Executive Chairman | Grant | A | 62.35 | 340 | 21,198 | 2,997,106 | 3 M to 3 M (+0.01 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Grant | A | 0.00 | 9,460 | 0 | 25,612 | 16.2 K to 25.6 K (+58.57 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | YOUNG KEVIN | Chief Operating Off ... | Grant | A | 62.35 | 340 | 21,198 | 16,152 | 15.8 K to 16.2 K (+2.15 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 2,323 | 0 | 132,083 | 129.8 K to 132.1 K (+1.79 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Gift | G | 0.00 | 2,323 | 0 | 5,393 | 7.7 K to 5.4 K (-30.11 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Payment of Exercise | F | 80.69 | 1,647 | 132,896 | 7,716 | 9.4 K to 7.7 K (-17.59 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 1,581 | 0 | 9,363 | 7.8 K to 9.4 K (+20.32 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 0.00 | 4,846 | 0 | 7,782 | 2.9 K to 7.8 K (+165.05 %) |
| Feb 23 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Grant | A | 62.35 | 221 | 13,779 | 2,936 | 2.7 K to 2.9 K (+8.14 %) |
| Feb 21 2018 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | EVP,Corporate &Medi ... | Sell | S | 81.54 | 14,435 | 1,176,992 | 0 | 14.4 K to 0 (-100.00 %) |
| Feb 13 2018 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Option Exercise | M | 26.62 | 60,000 | 1,596,900 | 0 | |
| Feb 13 2018 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Sell | S | 77.92 | 60,000 | 4,675,080 | 122,258 | 182.3 K to 122.3 K (-32.92 %) |
| Feb 13 2018 | GILD | GILEAD SCIENCES IN ... | WILSON GAYLE E | Director | Buy | M | 26.62 | 60,000 | 1,596,900 | 182,258 | 122.3 K to 182.3 K (+49.08 %) |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | Meyers James R | EVP Worldwide Comme ... | Option Exercise | A | 83.49 | 75,490 | 6,302,660 | 75,490 | |
| Feb 05 2018 | GILD | GILEAD SCIENCES IN ... | MILLIGAN JOHN F | President and CEO | Option Exercise | A | 83.49 | 295,660 | 24,684,653 | 295,660 |